| 中文名 | 2-(2,6-二氧代哌啶-3-基)-5-羟基异二氢吲哚-1,3-二酮 |
|---|---|
| 英文名 | 2-(2,6-dioxopiperidin-3-yl)-5-hydroxyisoindole-1,3-dione |
| 中文别名 |
2-(2,6-二氧代-3-哌啶基)-5-羟基-1,3-异吲哚啉二酮
4 - 羟基沙利度胺 沙利度胺杂质 2-(2,6-二氧哌啶-3-基)-5-羟基异吲哚啉-1,3-二酮 2-(2,6-二氧亚基哌啶-3-基)-5-羟基异二氢吲哚-1,3-二酮 2-(2,6-二氧代-3-哌啶基)-5-羟基-1H-异吲哚-1,3(2H)-二酮 4 - 羟基沙利度胺,10 MM DMSO 溶液 5-羟基沙利度胺 2-(2,6-二氧代 - 哌啶-3-基)-5-羟基 - 异吲哚-1,3-二酮 |
| 英文别名 |
4-Hydroxy thalidomide/Thalidomide-5-OH
Ligands for E3 Ligase,PROTAC,Inhibitor,Thalidomide5OH,inhibit,CRBN,E3 ligase-recruiting Moiety,Thalidomide,Thalidomide 5 OH 5-Hydroxythalidomide 2-(2,6-dioxo-3-piperidyl)-5-hydroxy-isoindoline-1,3-dione 2-(2,6-Dioxo-3-piperidinyl)-5-hydroxy-1,3-isoindolinedione 2-(2,6-dioxopiperidin-3-yl)-5-hydroxyisoindoline-1,3-dione Thalidomide-5-OH, 10 mM in DMSO 1H-ISOINDOLE-1,3(2H)-DIONE,2-(2,6-DIOXO-3-PIPERIDINYL)-5-HYDROXY Thalidomide Impurity 2 Thalidomide 5-Hydroxyisoindoline Impurity 2-(2,6-Dioxo-3-piperidinyl)-5-hydroxy-1H-isoindole-1,3(2H)-dione |
| 描述 | Thalidomide-5-OH 是一种基于 Thalidomide 的,可募集 CRBN 蛋白的 cereblon 配体。Thalidomide-5-OH 可通过 linker 与靶蛋白配体连接,形成 PROTAC 分子。 |
|---|---|
| 相关类别 | |
| 靶点 |
Cereblon |
| 参考文献 |
| 密度 | 1.611g/cm3 |
|---|---|
| 沸点 | 600ºC at 760mmHg |
| 分子式 | C13H10N2O5 |
| 分子量 | 274.22900 |
| 闪点 | 316.7ºC |
| 精确质量 | 274.05900 |
| PSA | 107.27000 |
| LogP | 0.00720 |
| 折射率 | 1.679 |
| 储存条件 | 室温,惰性气体保存 |
| 危害码 (欧洲) | Xi |
|---|
|
~59%
64567-60-8 |
| 文献:Nakamura, Takanori; Noguchi, Tomomi; Kobayashi, Hisayoshi; Miyachi, Hiroyuki; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2006 , vol. 54, # 12 p. 1709 - 1714 |
|
~%
64567-60-8 |
| 文献:Nakamura, Takanori; Noguchi, Tomomi; Kobayashi, Hisayoshi; Miyachi, Hiroyuki; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2006 , vol. 54, # 12 p. 1709 - 1714 |
|
~%
64567-60-8 |
| 文献:Nakamura, Takanori; Noguchi, Tomomi; Kobayashi, Hisayoshi; Miyachi, Hiroyuki; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2006 , vol. 54, # 12 p. 1709 - 1714 |
|
~%
64567-60-8 |
| 文献:Nakamura, Takanori; Noguchi, Tomomi; Kobayashi, Hisayoshi; Miyachi, Hiroyuki; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2006 , vol. 54, # 12 p. 1709 - 1714 |
|
~%
64567-60-8 |
| 文献:Nakamura, Takanori; Noguchi, Tomomi; Kobayashi, Hisayoshi; Miyachi, Hiroyuki; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2006 , vol. 54, # 12 p. 1709 - 1714 |
|
~%
64567-60-8 |
| 文献:Nakamura, Takanori; Noguchi, Tomomi; Kobayashi, Hisayoshi; Miyachi, Hiroyuki; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2006 , vol. 54, # 12 p. 1709 - 1714 |
|
~%
64567-60-8 |
| 文献:Nakamura, Takanori; Noguchi, Tomomi; Kobayashi, Hisayoshi; Miyachi, Hiroyuki; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2006 , vol. 54, # 12 p. 1709 - 1714 |
| 上游产品 4 | |
|---|---|
| 下游产品 0 | |